342 related articles for article (PubMed ID: 24835558)
1. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.
Biedenbach DJ; Bouchillon SK; Johnson SA; Hoban DJ; Hackel M
Clin Ther; 2014 Jun; 36(6):953-60. PubMed ID: 24835558
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Activity of Retapamulin and Antimicrobial Susceptibility Patterns in a Longitudinal Collection of Methicillin-Resistant Staphylococcus aureus Isolates from a Veterans Affairs Medical Center.
Harrington AT; Black JA; Clarridge JE
Antimicrob Agents Chemother; 2015 Dec; 60(3):1298-303. PubMed ID: 26666950
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
Woodford N; Afzal-Shah M; Warner M; Livermore DM
J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
[TBL] [Abstract][Full Text] [Related]
4. Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children.
McNeil JC; Hulten KG; Kaplan SL; Mason EO
Antimicrob Agents Chemother; 2014 May; 58(5):2878-83. PubMed ID: 24614375
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Baek YS; Jeon J; Ahn JW; Song HJ
Int J Dermatol; 2016 Apr; 55(4):e191-7. PubMed ID: 26892888
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
Candel FJ; Morales G; Picazo JJ
Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
Vingsbo Lundberg C; Frimodt-Møller N
Int J Antimicrob Agents; 2013 Sep; 42(3):272-5. PubMed ID: 23837927
[TBL] [Abstract][Full Text] [Related]
8. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS
Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713
[TBL] [Abstract][Full Text] [Related]
9. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
[TBL] [Abstract][Full Text] [Related]
10. Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus.
Weinberg JM; Tyring SK
J Drugs Dermatol; 2010 Oct; 9(10):1198-204. PubMed ID: 20941943
[TBL] [Abstract][Full Text] [Related]
11. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
McNeil JC; Hulten KG; Kaplan SL; Mason EO
Antimicrob Agents Chemother; 2011 May; 55(5):2431-3. PubMed ID: 21282426
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study.
Kircik LH
J Drugs Dermatol; 2012 Jul; 11(7):858-60. PubMed ID: 22777229
[TBL] [Abstract][Full Text] [Related]
13. Retapamulin Activity Against Pediatric Strains of Mupirocin-resistant Methicillin-resistant Staphylococcus aureus.
Patel AB; Lighter J; Fulmer Y; Copin R; Ratner AJ; Shopsin B
Pediatr Infect Dis J; 2021 Jul; 40(7):637-638. PubMed ID: 33657598
[TBL] [Abstract][Full Text] [Related]
14. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains.
Pastagia M; Euler C; Chahales P; Fuentes-Duculan J; Krueger JG; Fischetti VA
Antimicrob Agents Chemother; 2011 Feb; 55(2):738-44. PubMed ID: 21098252
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
Farrell DJ; Robbins M; Rhys-Williams W; Love WG
Antimicrob Agents Chemother; 2011 Mar; 55(3):1177-81. PubMed ID: 21149626
[TBL] [Abstract][Full Text] [Related]
16. The detection of mupirocin resistance and the distribution of methicillin-resistant Staphylococcus aureus at the University Hospital of the West Indies, Jamaica.
Nicholson AM; Thorns C; Wint H; Didier M; Willis R; McMorris N; Castle D; Maharaj N; Orrett FA
West Indian Med J; 2010 Oct; 59(5):509-13. PubMed ID: 21473397
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa.
Shittu AO; Udo EE; Lin J
BMC Infect Dis; 2009 Jan; 9():10. PubMed ID: 19175912
[TBL] [Abstract][Full Text] [Related]
18. Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic.
Rittenhouse S; Singley C; Hoover J; Page R; Payne D
Antimicrob Agents Chemother; 2006 Nov; 50(11):3886-8. PubMed ID: 17065626
[TBL] [Abstract][Full Text] [Related]
19. Retapamulin: a newer topical antibiotic.
Dhingra D; Parakh A; Ramachandran S
J Postgrad Med; 2013; 59(2):127-30. PubMed ID: 23793314
[TBL] [Abstract][Full Text] [Related]
20. Mupirocin resistance among Iranian isolates of Staphylococcus aureus.
Saderi H; Owlia P; Habibi M
Med Sci Monit; 2008 Oct; 14(10):BR210-3. PubMed ID: 18830185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
